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A B S T R A C T
Introduction. Urethral injury is an uncommon surgical complication of penile prosthesis (PP) surgery. Conventional
dogma requires abortion of the procedure if the adjacent corporal body is involved or delayed implantation to avert
device infection associated with urinary extravasation. Besides the setback of the aborted surgery, this management
approach also presents the possible difﬁculty of encountering corporal ﬁbrosis at the time of reoperation.
Aim. We report an approach using primary urethral repair and temporary suprapubic cystostomy for the manage-
ment of incidental urethral injuries in a cohort of patients allowing for successful completion of unaborted PP
implantation.
Materials and Methods. We performed a retrospective analysis of all patients receiving PPs from 1990 to 2014 in
which incidental urethral injuries were repaired and PP implantation was completed with suprapubic cystostomy
(suprapubic tube [SPT] insertion). After allowing for urethral healing and urinary diversion via SPT for 4–8 weeks,
the PP was activated.
Main Outcome Measures. Successful management was determined by the absence of perioperative complications
within 6 months of implantation.
Results. We identiﬁed four cases, all receiving inﬂatable PPs, managed with temporary suprapubic cystostomy.
These patients sustained urethral injuries during corporal dissection (one patient), corporal dilation (one patient),
and penile straightening (two patients). All patients were managed safely and successfully.
Conclusion. Primary urethral repair followed by temporary suprapubic cystostomy offers a surgical approach to
complete PP implantation successfully in patients who sustain urethral injury complications, particularly for complex
PP surgeries. Anele UA, Le BV, and Burnett AL. Suprapubic cystostomy for the management of urethral
injuries during penile prosthesis implantation. Sex Med 2014;2:178–181.
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Introduction
Penile prosthesis (PP) implantation is an effec-tive treatment option formanagement of erec-
tile dysfunction (ED) with >90% patient-reported
satisfaction rates [1,2]; however, this surgery can be
fraught with potential complication risks. Urethral
injury is an uncommon intraoperative complication
of PP implantation procedures with estimated
occurrence rates ranging from 0.1% to 3% [3–5].
These injuries occur during PP surgery, most com-
monly in the setting of penile ﬁbrosis [6]. When
they do occur, conventional dogma maintains that
the injury should be primarily repaired or, if small,
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allowed to heal over a urethral catheter. The pros-
thesis surgery should then be aborted, especially in
reference to cylinder placement within an adjacent
ruptured corporal body to reduce the risk of device
infection associated with urinary extravasation and
bacterial colonization [6,7]. Despite this standard
approach, evidence is lacking to support the neces-
sity for procedure termination. Furthermore,
delayed implantation following aborted surgery
presents a potentially increased level of difﬁculty
for subsequent PP surgery in the event of postsur-
gical corporal ﬁbrosis.
In this study, we present outcomes of an alter-
native approach for the management of incidental
urethral injuries using primary repair followed by
temporary suprapubic cystostomy for urinary
diversion and urethral convalescence with comple-




This was a retrospective evaluation of prospec-
tively followed patients undergoing PP surgery at
this institution during which urethral injury
occurred. The operative cases logs of the senior
surgeon (ALB) from 1990 to 2014 were examined.
Patients undergoing combined inﬂatable PP and
artiﬁcial urinary sphincter (AUS) implantation
procedures were included if the injury related to
the PP portion of the procedure. Cases involving
neophallic reconstruction were excluded.
Management Protocol
Our management protocol consists of primary
urethral injury repair and completion of the PP
surgery rather than abortion of the procedure.
Suprapubic cystostomy is then performed, which
entails ﬁlling the bladder with saline via urethral
catheter and insertion of a suprapubic tube (SPT)
using a suprapubic trocar cystostomy with guid-
ance under ﬂexible cystoscopy as needed. The ure-
thral catheter is maintained at the surgeon’s
discretion. PP (American Medical Systems [AMS],
Minnetonka, MN, USA; and Coloplast, Minne-
apolis, MN, USA) implantation is then completed
routinely [8]. The reservoir placement is advisedly
deferred after SPT insertion to avoid damage to
the reservoir before standard placement in the
right retropubic space. The PP is left deﬂated to
reduce any additional pressure at the surgical site.
Postoperatively, patients convalesce standardly
and are monitored with regular clinic follow-up
appointments.
Successful management is assessed by the
absence of perioperative complications, speciﬁ-
cally device infection, erosion or failure within 6
months of the procedure.
Results
Of 805 PP implantations procedures performed
from 1990 to 2014, 243 were done since this pro-
tocol was implemented in 2009. Of these 243
cases, only four (1.6%) (Table 1) were identiﬁed as
having intraoperative urethral injuries.
These cases represent four men ranging in age
from 65 to 78 (mean 71.3) years and manifesting
various comorbidities (Table 1). All presented with
postprostatectomy ED after failing conservative,
nonsurgical interventions over a mean interval of
8.3 (range 4–11) years and were implanted with
inﬂatable PPs. Patient 1 presented with a history
of three previous inﬂatable PP implantations and
removals associated with device infection. Patients
2 and 4 had urinary incontinence in addition to
ED, prompting combination AUS and PP implan-
tation procedures.
Intraoperative urethral injuries occurred at
various stages during the PP implantation proce-
dure, with two occurring during penile straighten-
ing maneuvers, speciﬁcally during penile modeling
Table 1 Demographic and clinical characteristics
Patient Age Race Comorbidities Etiology of ED
Duration
of ED (yrs) Previous therapies
1 68 White Htn, Tbc Post-Nerve-Sparing-RRP 7 PDE5i, MUSE, VED, IPP*
2 65 White Htn, HL Post-RRP & Salvage XRT 4 PDE5i, ICI, VED
3 74 White CAD, CABG, HL, Htn, former
Tbc, Peyronie’s disease
Post-RRP 11 PDE5i, ICI
4 78 White Htn, HL, former Tbc Post-RRP 11 PDE5i
CABG = coronary artery bypass graft; CAD = coronary artery disease; HL = hyperlipidemia; Htn = hypertension; ICI = intracavernosal injection; IPP = inflatable
penile prosthesis; MUSE = Medicated Urethral Suppository for Erection; PD = Peyronie’s disease; PDE5i = phosphodiesterase type 5 inhibitor; RRP = radical
retropubic prostatectomy; Tbc = tobacco use; VED = vacuum erection device; XRT = radiation therapy.
*History of previous IPP complicated by infection and requiring three component explantation procedures prior to presentation. yrs = years.
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to correct extreme ventral and dorsal curvatures
in patients 2 and 4, respectively. Additionally, one
injury occurred during manipulation of neighbor-
ing corporal tissues with dissection, and the
remaining one during corporal dilation (Table 2).
Each case had extensive intracorporal ﬁbrosis,
requiring corporoplasty. Patient 1 underwent
urethral reconstruction using a pedicled vascular
penile skin ﬂap to repair a 1 cm long defect. The
graft was then sewn in place with running 4-0
Maxon (Covidien, Dublin, Ireland) suture and
stented with a 14-French Foley catheter. The
reservoir was placed cephalad to the right
retropubic space in an ectopic position (beneath
the rectus abdominis musculature, between the
musculature and peritoneal lining) due to signiﬁ-
cant scarring from multiple previous procedures.
Patient 2 underwent a direct anastomotic
reapproximation of separated portions of urethra
using running and interrupted 4-0 Maxon suture.
AlloDerm (LifeCell Corporation, Bridgewater,
NJ, USA) was then sewn adjacent to the urethra
bilaterally at the location of the repair to provide
additional reinforcement. Patient 3 underwent
opening of the distal right side of the penis with
a separate corporotomy to expose the urethral
injury, and the urethra was subsequently repaired
with running 3-0 Monocryl (Ethicon, Inc.,
Somerville, NJ, USA) suture in a watertight
fashion. The corporotomy was then closed with
2-0 Vicryl (Ethicon, Inc.) suture. Patient 4 under-
went closure of the distal corporal bodies as
well as primary repair of the urethra with 3-0
Monocryl suture. All cases were unaborted, and
PP implantation was completed following
suprapubic cystostomy.
Urinary diversion via SPT was maintained for
4–8 weeks allowing for urethral healing (Table 2).
Periodic clinical follow-up visits were performed
every 2–4 weeks to assess healing. Approximately 4
weeks after SPT removal, PPs were activated. Of
note, patient 4 maintained his SPT management
for 12 weeks because of his poor ability to manipu-
late his AUS device pump and a resulting episode
of urinary retention. There were no device com-
plications (infection, erosion, or failure) after 6
months follow-up.
Discussion
The main purpose of this study was to present an
alternative surgical approach using suprapubic
cystostomy temporarily for urinary diversion in
order to complete traditionally aborted PP proce-
dures in patients sustaining intraoperative urethral
injuries. The prevalence of urethral injury found in
this study (1.6%) is consistent with the range
reported in prior studies [3–5]. We surmise that
the presence and extent of penile ﬁbrosis likely
accounted for this complication. Extensive
cavernosal atrophy and scarring often pose an
increased challenge during corporal dissection
and, as in two of our cases, penile reconstruction.
Radical prostatectomy, a known risk factor for cor-
poral ﬁbrosis [9,10], was common to all of our
patients. In addition, Peyronie’s disease, which
was present in patient 3 (Table 1), was also a risk
factor.
As we have described, SPT insertion can be
performed routinely without altering standard PP
implantation. It is recommended to insert the
SPT prior to placing the reservoir to avoid direct
injury to the reservoir. As demonstrated, urethral
injuries can occur in isolation; however, when
associated with corporal body involvement, the
use of inﬂatable PPs with delayed device activa-
tion offers the added potential beneﬁt of relieving
pressure at the site of injury compared with the
effect of malleable devices. We recognize that
particular circumstances may support aborting
the procedure; however, they are unique to each
operative case. Thus, the decision to complete
PP implantation in the setting of an urethral
injury must ultimately be based on patient spe-
Table 2 Surgical reconstruction and postoperative care





1 Penile skin reconstruction of urethral disruption during corporal dissection 8 12
2* Primary repair of urethral rupture during penile straightening maneuver 4 8
3 Primary repair of urethral rupture during corporal dilation 4 11
4* Primary repair of urethral and distal corporal body ruptures during penile
straightening maneuver
12 14
SPT = suprapubic tube; wks = weeks.
*Concurrent AUS insertion for urinary incontinence.
180 Anele et al.
Sex Med 2014;2:178–181 © 2014 The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Sexual Medicine.
ciﬁc assessments and relies on the level of expe-
rience and comfort of the surgeon. Consideration
must be given to the risks and beneﬁts associated
with aborted vs. unaborted procedures on an
individual case basis.
Limitations of this study are the small sample
size and the case-based nature of this investigation,
owing to the rarity of this intraoperative compli-
cation. We acknowledge the short-term follow-up
period of 6 months as for evaluating surgical com-
plications, emphasizing that our main purpose was
to present the feasibility of this management tech-
nique. We also acknowledge the contrariness of
this management recommendation; however, this
experience suggests an alternative option for
addressing this problem than aborting the surgical
procedure altogether. Although this approach has
been successful in this small series, we do not
propose this as a standard of care as further inves-
tigations are needed.
To our knowledge, this is the only report of its
kind speciﬁcally examining urethral injury during
PP implantation and its completion with man-
agement using temporary suprapubic cystostomy.
Although the occurrence rate of this complica-
tion is fairly low, it still does occur and can
greatly alter or delay operative planning and care.
The results of this study challenge traditionally
established dogma and demonstrate that urethral
injury may not require abortion of an implanta-
tion procedure. Primary urethral repair and tem-
porary suprapubic cystostomy offers a surgical
approach to complete PP placement successfully
in patients who sustain or are at risk for urethral
complications, particularly for complex PP
surgeries.
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